James Gifford

409 total citations
8 papers, 341 citations indexed

About

James Gifford is a scholar working on Surgery, Pharmacology and Epidemiology. According to data from OpenAlex, James Gifford has authored 8 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 2 papers in Pharmacology and 2 papers in Epidemiology. Recurrent topics in James Gifford's work include Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Liver physiology and pathology (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). James Gifford is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Liver physiology and pathology (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). James Gifford collaborates with scholars based in United States, Spain and Australia. James Gifford's co-authors include Roger T. Dean, W. Jessup, Leonard Kritharides, Jenő Gyuris, Lorena Lerner, Brian Krieger, Richard Nicoletti, Aminah Jatoi, Antonino Catanzaro and Rajesh Shinde and has published in prestigious journals such as Cancer Research, Analytical Biochemistry and Clinical Cancer Research.

In The Last Decade

James Gifford

8 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Gifford United States	5	101	97	79	74	72	8	341
R François United States	10	161 1.6×	85 0.9×	46 0.6×	190 2.6×	30 0.4×	28	429
Detao Gao United States	11	134 1.3×	47 0.5×	40 0.5×	45 0.6×	168 2.3×	18	439
Lijiang Shen United States	13	203 2.0×	35 0.4×	77 1.0×	19 0.3×	64 0.9×	15	361
Kjell Sverre Galdal Norway	11	97 1.0×	65 0.7×	59 0.7×	8 0.1×	71 1.0×	14	462
Shaoqian Sun China	10	121 1.2×	27 0.3×	37 0.5×	240 3.2×	45 0.6×	14	453
Umberto Pacetti Italy	6	53 0.5×	24 0.2×	56 0.7×	173 2.3×	8 0.1×	10	346
Michael La Belle United States	11	163 1.6×	39 0.4×	194 2.5×	11 0.1×	80 1.1×	16	468
E.A.L. Biessen Netherlands	7	130 1.3×	25 0.3×	136 1.7×	49 0.7×	99 1.4×	8	381
Xiufeng Zheng China	10	135 1.3×	20 0.2×	47 0.6×	111 1.5×	88 1.2×	24	435

Countries citing papers authored by James Gifford

Since Specialization

Citations

This map shows the geographic impact of James Gifford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Gifford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Gifford more than expected).

Fields of papers citing papers by James Gifford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Gifford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Gifford. The network helps show where James Gifford may publish in the future.

Co-authorship network of co-authors of James Gifford

This figure shows the co-authorship network connecting the top 25 collaborators of James Gifford. A scholar is included among the top collaborators of James Gifford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Gifford. James Gifford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

White, Brian H., James M. Quinn, Rossitza Alargova, et al.. (2019). Targeting the Somatostatin Receptor 2 with the Miniaturized Drug Conjugate, PEN-221: A Potent and Novel Therapeutic for the Treatment of Small Cell Lung Cancer. Molecular Cancer Therapeutics. 18(11). 1926–1936. 54 indexed citations

2.

Lerner, Lorena, Jenő Gyuris, Richard Nicoletti, et al.. (2016). Growth differentiating factor-15 (GDF-15): A potential biomarker and therapeutic target for cancer-associated weight loss. Oncology Letters. 12(5). 4219–4223. 45 indexed citations

3.

Tabernero, Josep, María Elena Elez, María Herranz‐López, et al.. (2014). A Pharmacodynamic/Pharmacokinetic Study of Ficlatuzumab in Patients with Advanced Solid Tumors and Liver Metastases. Clinical Cancer Research. 20(10). 2793–2804. 30 indexed citations

4.

Gifford, James, Kristan Meetze, William M. Winston, et al.. (2011). Abstract 644: Anti-tumor activities of antibodies targeting the RON receptor and a biomarker of response. Cancer Research. 71(8_Supplement). 644–644. 1 indexed citations

5.

Kritharides, Leonard, W. Jessup, James Gifford, & Roger T. Dean. (1993). A Method for Defining the Stages of Low-Density Lipoprotein Oxidation by the Separation of Cholesterol and Cholesteryl Ester-Oxidation Products Using HPLC. Analytical Biochemistry. 213(1). 79–89. 193 indexed citations

6.

Bailey, J.S., et al.. (1982). Homogeneous nonisotopic assay for phenytoin evaluated.. PubMed. 28(5). 1190–1. 3 indexed citations

7.

Gifford, James, et al.. (1982). Quantitation of haptens by homogeneous immunoprecipitation. 1. Automated analysis of gentamicin in serum.. Clinical Chemistry. 28(4). 659–661. 3 indexed citations

8.

Gifford, James & Antonino Catanzaro. (1981). A comparison of coccidioidin and spherulin skin testing in the diagnosis of coccidioidomycosis.. PubMed. 124(4). 440–4. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact